Unity Biotechnology Inc Long-term Investment Intensity

Latest as of March 2024: 3.3%

Unity Biotechnology Inc long-term investment intensity. Unity Biotechnology Inc (UBX) has a Long-term Investment Intensity of 3.3% as of March 2024. Long-term investments of $1.95 Million represent 3.3% of total assets of $58.86 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read Unity Biotechnology Inc (UBX) total liabilities for a breakdown of total debt and financial obligations.

LT Investment Intensity

3.3%
LT Investments / Total Assets

Long-term Investments

$1.95 Million
USD

Total Assets

$58.86 Million
USD

Country

USA
NASDAQ

Long-term Investment Intensity of Unity Biotechnology Inc (2017–2021)

Long-term investment intensity of Unity Biotechnology Inc from 2017 to 2021. This chart shows how Unity Biotechnology Inc's Long-term Investment Intensity has evolved across 4 annual periods from 2017 to 2021. As of March 2024, the intensity stands at 3.3%, reflecting long-term investments of $1.95 Million against total assets of $58.86 Million USD.

Unity Biotechnology Inc Long-term Investment Intensity by Year (2017–2021)

Unity Biotechnology Inc long-term investment intensity by year from 2017 to 2021. The table below presents the year-by-year Long-term Investment Intensity for Unity Biotechnology Inc from 2017 to 2021, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Unity Biotechnology Inc assets under control.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
2021 1.6% $1.99 Million $124.71 Million ▼ -9.8 pp
2020 11.4% $17.87 Million $156.32 Million ▲ +9.4 pp
2019 2.0% $3.02 Million $151.22 Million ▼ -3.0 pp
2017 5.0% $5.12 Million $102.02 Million —
pp = percentage points